Areva Pharma: FDA Temporarily Allowing Bupivacaine Import from Italy

Link to the Original Article: Local anesthetic drug supply: 132 in shortage, 13 available (beckershospitalreview.com) Local anesthetic drug supply: 132 in shortage, 13 available Paige Twenter – Thursday, January 19th, 2023 Between two types of local anesthetics, there are 132 in short supply and 13 available, according to the American Society of Health-System Pharmacists.  Here’s how the

Areva Pharmaceuticals is proud to now support FSS/VA contract 36F79721D0112

Areva Pharmaceuticals is pleased and honored to be awarded the below products on the VA/FSS contract, contract number 36F79721D0112. t NDC Strength Carton Item Number Bupivacaine 59923-0717-05 0.25% 5ml 10 ampules 3985900 Bupivacaine 59923-0718-05 0.5% 5ml 10 ampules 3985926 Bupivacaine 59923-0719-10 0.25% 10ml 10 ampules 3985918 Bupivacaine 59923-0720-10 0.5% 10ml 10 ampules 3985934 Product NDC

Areva Pharmaceutical announces its approval to supply the Veterans Administration and the DOD as a minority WOMB(Women Owned Minority Business)

Areva Pharmaceuticals announced it has received its full approval to supply critical drugs need to service the Veterans Administration and the Department of Defense under the Women Owned Minority Business category. “Areva Pharmaceuticals is pleased to serve the nations veterans and the defense department with critical need drug that has seen an increased demand due

Areva implementing CDC Guidelines

Areva Pharmaceuticals is an esential business and has felt the impacted by COVID-19. We continue to monitor and follow CDC recommendations regarding care and prevention, and explore ways to further reduce risk including urging our employees to be mindful of their activities outside of the workplace to reduce their risk of bringing the virus into

Areva Pharmaceuticals launches Bupivacaine HCl Injection Covid-19 Drug shortage in the US healthcare System

Georgetown, Indiana.  Areva Pharmaceuticals announced  it is working with large IDN’s and hospital systems to help mitigate Bupivacaine HCL Injection shortage, USP in 0.25mg/ml, 0.5mg/ml  currently in the US Healthcare System “Areva Pharmaceuticals is very pleased to work with the US FDA and in a short time receive its temporary approval to help with the current

US FDA Approve Areva’s Verapamil HCl Injection for the US Market

Areva Pharmaceuticals announced it has received U.S. Food and Drug Administration (FDA) approval for Verapamil HCl, USP in 5mg/2ml and 10mg/4ml vial. It is an AP-rated generic injection to ISOPTIN® INJECTION “Areva Pharmaceuticals is very pleased to announce the approval of Verapamil HCl.  This approval further cements Areva’s commitment to bringing sterile injectable products to produced exclusively